Showing results (21-30 of 302) with videos related to
Sort By:
Pageof 31
Cancer Cell|September 22, 2023
A single-cell atlas of CD19 chimeric antigen receptor T cellsXubin Li, Jared Henderson, Max J Gordon, et al.Case Reports in Medicine|July 20, 2012
Hodgkin lymphoma untreated for six years presenting with tracheoesophageal fistulaJason R Westin, Amye Gibbs, Keith R Mills, et al.Oncotarget|February 18, 2016
Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironmentHan Zhang, Zheng Chen, Sattva S Neelapu, et al.Haematologica|September 10, 2002
Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccinesPier Adelchi Ruffini, Sattva S Neelapu, Larry W Kwak, et al.Current Topics in Microbiology and Immunology|June 16, 2010
Identification of human idiotype-specific T cells in lymphoma and myelomaJinsheng Weng, Sattva S Neelapu, Alison F Woo, et al.Journal for Immunotherapy of Cancer|October 9, 2025
Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapyPaolo Strati, Amanda Brandt, Anath C Lionel, et al.Blood Advances|March 3, 2022
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapySushanth Gouni, Allison C Rosenthal, Jennifer L Crombie, et al.Drugs & Aging|May 6, 2019
Treating Older Patients with Chronic Lymphocytic Leukemia: A Personalized ApproachPaolo Strati, Alessandra FerrajoliEjhaem|September 1, 2020
Partial omission of bleomycin for early-stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?Jillian R Gunther, Chelsea C Pinnix, Gordon R Glober, et al.Frontiers in Oncology|July 17, 2020
CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World ExperiencesCandida Vitale, Paolo StratiPageof 31